US9610260B2
US9610260B2 - Method for the treatment of Dravet Syndrome
A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an ...
Method for the treatment of Dravet Syndrome - Patent US-9610260 ...
https://patents.google.com/patent/US9610260B2. PubChem. https://pubchem.ncbi.nlm.nih.gov · PubChem on X · PubChem on Facebook · PubChem Help. Connect with NLM.
US9610260B2 - Method for the treatment of Dravet ... - Google Patents
US9610260B2 ; 2014-07-30. Application filed by UNIVERSITY HOSPITAL ANTWERP, Katholieke Universiteit Leuven ; 2014-07-30 ; 2014-11-20 ; 2017-04-04. Application ...
US20170151257A1 - Method for the treatment of dravet syndrome ...
US14/447,253 Active US9610260B2 (en), 2013-05-03, 2014-07-30, Method for the treatment of Dravet Syndrome. US14/447,303 Active US9603814B2 (en), 2013-05-03 ...
US9610260B2, UCB INC, FENFLURAMINE HYDROCHLORIDE, FINTEPLA, 25 Jun, 2020. Elixir. 03 May, 2033. {"application_id":8930,"application_number":"US16431391 ...